• Science and Research

  Personalized CF Medicine to be Tested for Rare Genetic Defects in Europe

  Posted by cystic-fibrosis-news-moderator on January 7, 2020 at 11:32 am

  

  Three therapies (PTI-801, PTI-808, and PTI-428) by Proteostasis Therapeutics showed promising results in patient-specific lab models, the company has announced. Click here to read the full story.

  What do you think of this news?

  cystic-fibrosis-news-moderator replied 4 years, 3 months ago 0 Member · 0 Replies
• 0 Replies

Log In to Reply